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INTRODUCTION
Prof. Cigna’s otherwise detailed review of the radon 
problem in caves (Cigna, 2005) gives insufﬁcient 
attention to the confounding inﬂuence of radon on 
the aetiology of lung cancer, which is better known 
for being associated with tobacco rather than with 
radon. Although for ethical reasons a cause and 
effect relationship has not been and never will be 
proved, there is no physician who does not believe 
that smoking causes lung cancer. In every country 
the increase in incidence of, and mortality from, lung 
cancer coincides, after a latent period, with the rise 
in tobacco consumption. The risk of lung cancer 
increases with the number of pack years smoked. It 
is a rare disease in non-smokers (Spiro, 1996), and 
“predominant” among uranium miners who smoke 
(Archer et al., 1973). Despite solid evidence that 
radon is a carcinogen, and that the risk rises with 
time of exposure (usually many years) and increased 
concentrations of radon, expressed in Bequerel per 
cubic metre (Bq/m3) in conﬁned spaces, such as 
homes and caves (Darby et al., 2005) the risk varies 
with climate and geographical location. Because of 
the short times that casual cavers are exposed to 
radon, the risk of developing a lung cancer for a non-
smoking caver can be considered very small; the risk 
is compounded for smokers. All people are at some 
risk due to radon as there is a ubiquitous background 
concentration of radon at around 40 Bq/m3 (USA), and 
about half that amount (United Kingdom), in the air.
 THE HISTORICAL EVIDENCE  
FOR RADON AS CARCINOGEN 
Titus Lucretius Carus, cited by Cigna (2005), 
addressed the dangers of mining in three sentences: 
“… what stenches Scaptensula breathes out 
underground? And what poison gold mines may 
exhale! How strange they make men’s faces, how 
they change their colour! Have you not seen or heard 
how they are wont to die in a short time and how 
the powers of life fail those whom the strong force of 
necessity imprisons in such work?” (Bailey, 1972).
This merely tells us that ancient Greek gold miners 
had a short life expectancy, and hints that the cause 
was respiratory in origin.
Lucius Annaeus Seneca, also cited by Cigna 
(2005) is even more vague. He gives Asclepiodotus 
as the source of his information, and conﬁrms the 
dangerous nature of mining without giving any detail 
thereof. His extravagant mention of, “… huge rivers 
and vast reservoirs of motionless water, equal to ours 
above ground … but with a vast free space overhead” 
contributes nothing to discussion of the radon problem 
(Corcoran, 1972).
Georgius Agricola, who is misquoted and therefore 
misinterpreted by Cigna (2005), is a more reliable 
witness. He is well known in mining and metallurgical 
circles because of his textbook of mining, De Re 
Metallica, which was published posthumously in 1556. 
For the next 180 years it was the only available guide 
for miners and metallurgists, and was widely read. It 
has since become a very scarce collector’s item, but 
the 1950 reprint of the 1912 English translation is 
more readily available.
Agricola was also a physician who trained in 
Italy. In 1527 he was appointed town physician at 
Joachimstal (now Jáchymov) on the Bohemian side of 
the metalliferous Erzgeberg. In about 1533 he crossed 
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the mountains to be town physician at Chemnitz in 
Saxony. Agricola can therefore be expected to have 
attended the miners. His book indicates that he was 
familiar with the occupational diseases and hazards 
of mining. He described the effects of foul air, cold and 
wet conditions, heavy metal toxicity and accidents. 
He also recorded the respiratory diseases of miners, 
and attributed them to dust. It is worth quoting him 
verbatim:
“… penetrates into the windpipe and lungs, and 
produces difﬁculty in breathing, and the disease 
which the Greeks call άσθμα.”
“… it eats away the lungs, and plants consumption in 
the body” (Hoover & Hoover, 1950). Although Agricola 
made no claim to have performed autopsies on his 
patients, he must have done so, or he would not have 
discovered that whatever disease he was describing 
“eats away the lungs”.
The former description is compatible with silicosis 
and pneumoconiosis, the latter with tuberculosis 
– all traditional diseases of miners. No description is 
compatible with lung cancer, which is a macroscopically 
localised pulmonary disease which does not, “eat 
away the lungs”. Tuberculosis is an infectious 
disease caused by the bacterium Mycobacterium 
tuberculosis which causes liquefaction of lung tissue 
and subsequent cavities (Davies et al., 1996). In other 
words it, “eats away the lungs”.
Pneumoconiosis is a chronic ﬁbrotic lung disease 
caused by inhalation of coal-mine dust. Silicosis is a 
chronic ﬁbrotic lung disease caused by inhalation of 
silicon dioxide dust, and has been recognised in metal 
miners and stone masons for centuries (Seaton, 1996). 
Ancient miners, using hammers and chisels, raised 
much less dust than do their mechanised modern 
counterparts, but they were working in enclosed 
spaces and would have inhaled signiﬁcant quantities 
of dust. By comparison stone masons work in the open 
air, using hammers and chisels. Despite the absence 
of conﬁnement they suffered, and continue to suffer, 
from silicosis.
The Erzgeberg mines contain radioactive pitchblende, 
from which radium was ﬁrst extracted by Marie Curie 
(Curie, 1898; Curie & Bémont, 1898). Radium decays 
through, inter alia, radon to lead (Mark et al, 1982). 
Gaseous radon and its microparticulate daughters 
readily enter the lungs. They therefore irradiate the 
trachea and bronchi.
The Erzgeberg miners formed the population in 
which lung cancer was ﬁrst described in 1879, and 
in which a 20 year exposure to mine conditions was 
required for the cancer to develop. Three quarters of 
these patients had died of pulmonary malignancy. 
The authors of this detailed investigation into the 
“bergkrankheit” were aware that it had previously 
been misdiagnosed as pulmonary tuberculosis. 
They enquired at the distant mining communities of 
Modum in Sweden and Dobschau in Hungary, and 
ascertained that no lung cancer had been reported 
there (Härting & Hesse, 1897a, 1897b & 1897c). If 
it were assumed that the miners commenced their 
hazardous occupation while still in their teens, they 
could be expected to have developed their lung cancers 
by the age of 35 years or shortly thereafter. 
Agricola made no distinction between the 
occupational diseases of the Erzgeberg miners and 
those of miners elsewhere. It is therefore questionable 
whether at that tobacco-free time the incidence 
of lung cancer in European miners differed from 
that in non-miners. It must then have been a very 
rare disease. Tobacco was introduced to Europe in 
1556 (Encyclopaedia Britannica, 1968), too late to 
have confounded Agricola’s observations on miners’ 
occupational diseases.
The failure of Agricola to report any respiratory 
disease peculiar to the Erzgeberg miners, and which 
was compatible with lung cancer, suggests that radon 
is only a minor factor in the causation of lung cancer. 
It is probably the synergistic effect of the radon on 
tobacco smoke that is responsible for the lung cancer 
of workers in radio-active mines. An alternative 
explanation may be that the 16th. century Erzgeberg 
miners did not live long enough to develop lung 
cancer. One twentieth century case report describes 
a patient with the bergkrankheit at 51 years of age, 
and whose father died of the same disease at 42 
years (Löwy, 1929). Thereafter a historian of Europe 
misinterpreted this as indicating a life expectancy of 
42 – 43 years (Wiskemann, 1938).
More recently, Saccomanno et al.(1996) found 
that smokers who are also miners have a 9·3% 
higher incidence of lung cancers than non-mining 
smokers and that lung cancer was increased in 
cigarette smoking miners and non-miners, but that 
the proportion of lung cancers in the “central zone” 
was signiﬁcantly greater in miners than in non-
miners. The higher percentage of central tumours 
in the miners was primarily due to the distribution 
of a greater proportion of squamous cell and small-
cell tumours. In the mining cohort, there were ten 
times as many small-cell tumours in the central 
area as in the middle and peripheral regions versus 
only ﬁve times as many centrally located tumours as 
middle and peripheral tumours in the non-miners. 
The authors conclude that inhaled dust, radon and 
cigarette smoke combine to form large particles that 
deposit in the central bronchial tree, but that ﬁltered 
smoke free of dust form smaller particles that deposit 
more peripherally. Obviously, the non-miners were 
exposed to only home or free-air radon levels, and 
the distribution of the cancers in miners and non-
miners clearly differed. The alpha dose distribution 
determined by aerosol deposition and clearance may 
preferentially cause tumours at different sites, i.e. a 
larger dose proximally may affect tall columnar goblet 
cells or metaplastic squamous epithelium cells, while 
a smaller dose distally may affect bronchiolar, Clara 
or Type II cells.
Fifty eight per cent of miners were smokers 
compared with 35% of non-miners. Of the total cohort 
of 476 miners with lung cancer, only 24 were non-
smokers. The overall exposure of miners to radon 
decay products was known and revealed that 54% 
of smokers and 66% of non-smokers had exposures 
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greater than 1000 WLM. Smokers therefore had an 
excess of cancers 19·8 times that of non-smokers 
despite the higher exposure of non-smokers.
 
EPIDEMIOLOGICAL STUDIES:  
THE RISK FOR LUNG CANCER DUE TO 
EXPOSURE TO SMOKING
The epidemiological data relating lung cancer risk to 
smoking were summarised in a report from the United 
States Ofﬁce on Smoking and Health (Koop, 1982) and 
by Wynder and Hoffman (1994).
The major etiological factor in the causation 
of lung cancer is the smoking of tobacco, mainly 
cigarettes. Bronchogenic carcinoma is without 
doubt the greatest neoplastic killer in industrialised 
countries; it accounts for 35% of the cancer deaths 
in the United States. Since 1985, lung cancer also 
surpassed breast cancer in females. This is in sharp 
contrast to most other cancers, the incidence of which 
either stayed constant or declined slightly. The major 
cause of lung cancer has long been recognised to be 
cigarette smoking; male cigarette smokers are 10 to 
20 times more likely to die of lung cancer than non-
smokers. Statistically, there is a linear correlation 
between the frequency of lung cancer and the pack-
years of smoking (Frank, 1982). About 80% of lung 
cancers occur in current smokers.
Evidence for the relationship between smoking and 
lung cancer is derived from clinical, epidemiological 
and experimental studies.
 
Pathogenesis
The clinical (pathology based) evidence relates 
to the progressive changes in the epithelium of the 
respiratory tract of habitual cigarette smokers. 
Firstly, there is a loss of the cilia, followed by typical 
squamous metaplasia, replacing the mucous goblet 
cells and pseudo-stratiﬁed columnar cells. This is 
followed by dysplasia and eventually abnormalities 
approaching carcinoma in situ, followed by frankly 
invasive bronchial (lung) carcinoma (Auerbach, 
1979). 
It should also be kept in mind that not only smoking, 
but also chronic bronchitis, can lead to squamous 
metaplasia, so that not only smokers are exposed to 
this thinning and potentially pre-cancerous lesion 
(Geneser, 1986). 
 
Histogenesis of lung cancer
Which is the target cell in terms of carcinogenesis, 
and can an alpha particle reach these cells?
Most of the evidence suggests that proliferating cells 
of the mucosa give rise to lung tumours. Two cell types 
proliferating in the mucosa are the secretory (goblet) 
cells and the basal cells. Both of these cell types are 
within 50 micrometres of the airway surface and may 
be reachable by the alpha particles. (McDowell et al. 
1978 and 1993). In the peripheral airways, Clara cells 
or Type II pneumocytes are implicated as precursor 
cells for the non-mucosal subtype of bronchiolo-
alveolar tumours. Endocrine (APUD) cells (Krause & 
Cutts, 1981; Geneser, 1986) are other occupants of 
the epithelium. Small cell carcinomas, 20 to 25% of the 
common lung cancers, may have the neuro-endocrine 
or APUD cells as cell of origin (Robbins and Kumar, 
1987; Saccomanno, 1988) and are strongly associated 
with smoking and radon exposure (Darby 2005). 
These data suggest that the basal cells are towards 
the limit of the range of alpha particles or just out of 
range. The epithelium, changed after metaplasia and 
dysplasia, will not be “horny” like skin, but rather soft 
like moist epithelium, such as may be encountered in 
the vagina. The basal cells of the altered epithelium 
here should be in easy reach of alpha particles.
At the bottom of the epithelium are the basal 
cells, stem cells that replace worn-out ciliated and 
goblet cells (Moran & Rowley, 1988). This epithelium 
covers the trachea and bronchi, and seems to have a 
thickness on histological preparations of about 90 to 
100 microns. The in vivo thickness of the epithelium 
may be thicker because with histological slide 
preparation there is a degree of shrinkage, and the 
mucus layer may be washed off.
Experimental studies
Cigarette smoking could be shown to induce DNA 
single strand breaks in human cells (Nakayama, 1985). 
Furthermore, it is well recognised that environmental 
and other factors can enhance the carcinogenicity of 
cigarette smoke, for instance the increased incidence 
in miners due to, not only radioactive materials, but 
also to asbestos, arsenic, chromium, uranium and 
nickel (Robbins & Kumar, 1987).
The radioactive material under suspicion is mostly 
radon gas emanating from uranium and radium in 
rocks, and the radioactive non-gaseous “daughters”, all 
emitting alpha particles. Uranium and radium found in 
granite rocks disintegrate slowly with the emission of 
radon which decays by alpha particle emission to leave 
behind the radon daughters, which are nongaseous 
micro-particles which may be captured in the lung, 
continuously emitting alpha particles. Alpha particles 
end up after electron capture as helium. Eventually 
the mother molecules of uranium and radium end up 
as stable lead. An alpha particle has two neutrons and 
two protons, each of the two protons carrying a unit 
of positive charge; and both alpha particles as well 
as the negatively charged daughters can be attracted 
electro-statically to dust particles. 
Radiobiological considerations
Alpha particles have contradictory qualities as a 
candidate carcinogen in the lung. On the one hand 
a very short range – about 45 to just less than 100 
microns in a watery medium - an alpha particle 
cannot penetrate a sheet of paper, or the horny 
layer of the skin. For 5·5 MeV alpha particles, for 
instance, the range in air (density 1·2 mg/cm3), is 
about 3·7 centimetres, in paper (density 0·89 g/cm3) 
53 micrometres and in water (density 1·0 g/cm3) the 
range of an alpha particle is 45 micrometres.
On the other hand, the short range is compensated 
for by the fact that an alpha particle is densely ionising 
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and therefore very capable of causing profound 
damage to a cell if the nucleus should be traversed. 
In its short path it strips many electrons off nearby 
molecules in contrast to X- or gamma rays (photons) 
which on the other hand are very penetrating, but 
sparsely ionising. Alpha particles will lose about 80 
to 150 keV per micrometre in cells, as opposed to 
beta particles, which will yield about 0·1 to 3 keV per 
micron and even less for photons.
Densely ionising radiation causes many double 
strand breaks that are difﬁcult for the damaged cell 
to repair. The single strand breaks usually caused by 
sparsely ionising radiation, like photons, are much 
easier for the cell to repair (Hall, 1988a & 1988b).
Cancer is more likely to arise in damaged DNA, but 
not so damaged that the cell is reproductively dead. 
In this regard, it has been shown that in isolated 
cells alpha particles are very effective cell killers 
and damagers of chromosomes. Many studies over 
the past 30 years agree that the cell survival curve 
can be represented accurately from a single straight 
line in the conventional exponential plot with a 
Do of 0·6 for human cells exposed to alpha particle 
irradiation. Simmons et al.(1996) found that on 
average only three alpha particles must traverse the 
nucleus for a mean lethal dose for a human lung cell, 
representing an energy exchange of only 1·0 MeV. The 
rate of chromosome aberration induction can also be 
described by straight lines with slopes of 0·3 and 0·6 
respectively for V79 and human lung cells. 
However, newer evidence that alpha particles may 
not have the nucleus as the only target is emerging. 
Evidence for a so-called “bystander effect” is mounting. 
The alpha particles will generate chemical radicals if 
the cytoplasm alone is hit. These chemical radicals 
may cause indirect damage at a short distance from the 
ionisation locus (Hall, 1988a & 1988b). In this regard, 
there is supporting evidence for an extra-nuclear target 
for alpha particle irradiation. Deshpande et al. (1996) 
investigated the relationship between nuclear hits 
and the subsequent occurrence in sister chromatid 
exchange in normal human lung ﬁbroblasts. This may 
result in accumulations of the cell cycle regulating 
protein p53 in immortalised rat lung epithelial cells 
in a higher percentage of the exposed population than 
expected. These ﬁndings point to the possibility that 
the DNA effects of alpha radiation may not be initiated 
exclusively in a cell’s nuclear compartment, and may 
imply that a direct hit on a cell is not needed to induce 
malignant transformation in a cell. This work has 
been elegantly corroborated by Wu et al. (1999) who 
showed that selective irradiation of the cytoplasm 
could be mutagenic, and that this mutagenicity 
was due to the generation of oxygen species and is 
accomplished by little or no killing of the target cells 
leaving, in principle, the cells enough time to undergo 
malignant transformation.
Similar ﬁndings were recorded by Zhou et al. (2000 
& 2001). The latter paper provides clear evidence 
that alpha-irradiated cells can induce a bystander 
mutagenic response in neighbouring cells not directly 
traversed by alpha particles, and that a cell-cell 
communication process may play a critical role in 
mediating the bystander phenomenon. This implies 
some signal transduction at distances longer than the 
range of, for instance, hydroxyl radicals with a range 
of only about 4 nano-metres (Wu, 1999). 
 
RECENT EPIDEMIOLOGICAL STUDIES 
Radon alone as a causative factor for lung cancer
The Iowa Radon Lung Cancer Study (Field et al., 
2000) studied 1000 housewives exposed for 20 years 
to relatively high values of radon in their homes in 
order to assess radon as a factor in causing lung 
cancer. Sixty per cent of the homes exceeded, for 
cases and controls, the action level of 4 pCi/L (148 
Bq/m3). Risk estimates were adjusted for age, active 
smoking and education. The results suggested that 
cumulative exposure to radon is a signiﬁcant factor for 
lung cancer in women. For all lung cancer subtypes 
there was a positive categorical trend (p=0·05). The 
study estimated excess odds of average 0·5, for radon 
levels approximately equivalent to a 15 year exposure 
at an average radon level of 4 pCi/L (148 Bq/m3). The 
conclusion was that radon is a signiﬁcant risk factor 
for developing lung cancer. 
Meta-analysis of epidemiological studies
A study that will probably stand as a landmark is 
a meta-analysis of the role of radon in homes with 
regard to the development of lung cancer (Darby et al., 
2005). It is presented here in some detail.
Radon 222 and its decay products are responsible 
for probably half of the background, non-medical, 
exposure to radiation in many countries. The authors 
stress that air pollution by radon is ubiquitous. 
Concentrations are low outdoors, but can build up 
indoors, like in homes (and caves). The highest 
concentrations occur underground, especially in 
uranium mines. This collaborative study included 13 
case control studies in 9 European countries each of 
which registered over 150 people with lung cancer and 
150 or more controls, and which included data about 
radon levels over 15 years or more of observation. The 
available radon measurements covered a mean of 23 
years. The analysis included 7148 people with lung 
cancer and 14,208 controls. For cases of lung cancer, 
the mean measured radon concentration was 104 Bq/
m3 while for controls the weighted average of the study 
speciﬁc means was 97 Bq/m3. The risk of lung cancer 
versus the radon concentrations (after stratiﬁcation 
for study, age, gender, region of residence and 
smoking) was found to be increased by 8% per 100 
Bq/m3 increase in radon concentration. The authors 
distinguished between measured radon and “usual 
radon” which is the radon level after correction for 
the dilution of radon data caused by uncertainties in 
measuring radon concentrations. For “usual radon” 
concentration, the risk for developing lung cancer 
is said to be 16% per 100 Bq/m3 increase in radon 
concentration. The dose response relationship was 
linear even down to levels of >200 Bq/m3 (the so-called 
“action level”).
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If smoking had been omitted from the stratiﬁcation 
of cases, the risk of lung cancer would only have 
increased by 2·3% per 100 Bq/m3 increase in 
measured radon.
The authors concluded that the lifelong risk of lung 
cancer by age 75 would be 0·41%, 0·47%, 0·67% and 
0·93% for lifelong non-smokers, versus 10·1%, 11·6%, 
16·0% and 21·6% in cigarette smokers, for levels of O, 
100, 400 and 800 Bq/m3 respectively. Furthermore, 
that if the proportionate increases in risk per unit 
exposure are approximately independent of smoking 
history, then as lung cancer is much commoner in 
cigarette smokers than in lifelong non-smokers, radon 
poses a much grater absolute hazard to cigarette 
smokers, and to recent ex-smokers, than to lifelong 
non-smokers. Table 1 shows the results.
For lifelong non-smokers, they found that the 
increase in risk per 100 Bq/m3 was 10·6%. The average 
radon concentration in dwellings in Europe is about 59 
Bq/m3 which implies a risk to people spending much 
time in their homes of about a 9% risk of developing 
lung cancer, or about 2% of all cancers.
RISK ESTIMATES FOR CAVERS  
EXPOSED TO RADON
From an internet derived article on “Caving in 
Ireland”  http://www.cavingireland.org/safety/radon.
htm the authors estimated the recreational caver 
spending 50 hours per year caving to have a lifetime 
risk of 1 in 12500 or 0·00008. For professional cavers, 
the lifetime risk is estimated, assuming 600 hours per 
year caving, for premature death from lung cancer, to 
be 1 in 1000.
No distinction is made between the risk to smokers 
and non-smokers. Against this background, the 
estimated risk of death due to accidents during a 
single caving trip is 1/40,000 or for 50 trips, 0·00125, 
that is, again, 1·25 deaths per 1000 cavers per year. 
The authors estimate the risk of a fatal lung cancer 
developing as a result of a single 4 hour exposure 
to 7000 Bq/m3 as about 1/3 to 1/4 of the estimated 
risk due to an accident. This article cites the ICRP 
recommendation of  the adoption of a risk factor of 
0·0001 for developing lung cancer to chronic exposure 
of radon gas concentration of 1 Bq/m3. The risk to 
the general UK population therefore should be 40 x 
0·0001 or 0·004. The above risk estimates are based 
on this recommendation.
Hyland and Gunn (1994) found levels of radon in 
British caves varying from 484 Bq/m3 to 8868 Bq/
m3. The mean concentrations for integrated (dose 
measured over several days and averaged) fall in the 
range 2,300 Bq/m3 to 3,300 Bq/m3 but the means from 
spot measurements vary much more due to diurnal 
variations in radon concentration. For example, a spot 
measurement from Giant’s Hole in Derbyshire showed 
a radon concentration of 155,000 Bq/m3. Radon 
gas concentrations (Bq/m3) have been converted to 
effective dose equivalents (mSv). The average annual 
background concentration of radon in the UK is 20 
Bq/m3, which translates to a dose of 1·25 mSv per 
year. A single 4 hour trip in a cave could reach this 
level of exposure. Fifteen mSv could be reached in 33h 
to 3,333h depending on the cave and region. This is a 
more than a 100 fold variation in concentration.
 
Calculation of risk to speleologists due to radon 
based on the data supplied by Darby et. al. (2005)
 
Radon Level (Bq/m3)       0 100 400 800
Risk to non-smokers% 0·41 0·47 0·67 0·93
Risk increase% 
per 100 Bq/m3            14·6 14·2 9·7
Risk to smokers%               10·1 11·6 16·0 2·6
Risk increase%  
per 100 Bq/m3 14·9 28·7 8·75
Smoker/non-smokers               24·6 24·6 23·9 23·2
 
Table 1 shows a virtually constant excess risk of about 
25 times the risk for smokers to develop lung cancer 
compared to non-smokers. In non-smokers exposed 
to 800 Bq/m3, only about 9 out of 1000 people at age 
75 can expect to die from lung cancer, whereas about 
216 smokers per 1000 of the population can expect to 
meet this fate. Of the 9, a signiﬁcant proportion of the 
public will be exposed to the natural concentration of 
radon in the free air, or about 20 Bq/m3 (UK) or about 
40 Bq/m3 in the USA. “Action levels” are advised at ten 
times this level, or 200 Bq/m3 in the UK. The authors 
quote an increased risk of lung cancer of 16% per 100 
Bq/m3 of radon. A smoker with risk x, will therefore 
have a risk of x + 16% at 100 Bq/m3 , x + 32% at 200 
Bq/m3 , x + 48% at 300 Bq/m3 , and x + 112% at 700 
Bq/m3. The table also suggests a “saturation effect” in 
the sense that the increase in risk at 800 Bq/m3 is 
9·7% versus 14·6% and 14·2% at 100 and 400 Bq/m3 
respectively for non-smokers, and 8·75% at 800 Bq/
m3 for smokers but 14·9% and 28·7% for smokers, 
although the relative risk remains at about 24 times 
the risk for smokers versus non-smokers. The risk 
estimates at levels above 400 Bq/m3 may therefore be 
too high if the risk is plot as a straight line function. 
However, risk may not disappear at very low levels of 
radon. Since there seems to be a linear relationship 
between level of exposure and risk then additional 
columns can be added to table 1 to produce table 2, 
to consider the effects when the data are extrapolated 
to include radon levels as high as 7000 Bq/m3 . 
Miners exposed to 1000 WLMs (see Saccomanno et 
al. 1996 above) = 7·4 x 103 Bequerel per cubic metre 
= 74 multiples of 100 Bq per cubic metre. The risk 
Table 1. Lifelong cumulative absolute risk of death due to lung cancer 
at age 75 years for individuals exposed to escalating levels of radon 
in homes (Expanded from Darby et. al. 2005)
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to smoking miners (ignoring the effects of dust etc., 
must therefore be, ignoring “saturation dose effects” 
74 x 1·4 or 103·6 times that of the general population, 
and for non-smokers 74 x 0·06 = 4·4 times the risk to 
the general population, using the risk estimates from 
Darby et al. (2005), table 2. 
Radon Level (Bq/m3) 0 100 400 800 7000
Risk to non-smokers% 0·41 0·47 0·67 0·93 3·72
Risk % per 100 Bq/m3 0·06 0·066 0·065 0·6
Risk to smokers% 10·1 11·6 16·0 21·6 86·8
Risk % per 100 Bq/m3 1·5 1·46 1·4 14
Smoker/non-smokers 24·6 24·6 23·9 23·2 23·3
Risk% to non-smokers exposed 
for 50 hours p.a to 7000 B/m3                                                                          0·00028
Risk% to smokers exposed for 50 hours p.a.                   0·0066
  
Table 2. Lifelong cumulative absolute risk of death due to lung 
cancer at age 75 years for individuals exposed to escalating levels 
of radon in homes (Expanded from Darby et al. 2005). Risk levels for 
speleologists are extrapolated from these data for exposure to 7000 
Bq/m3 for 50 hours per annum.
   
Calculation of the risk to speleologists on the basis 
of the above data
The hours in 75y are (75 x 365·25 x 24) = 657450 
hours. Therefore the risk of developing lung cancer 
for an exposure, for non-smokers, to 50 hours in a 
cave with 7000 Bq/m3 would be 0·00028%. Darby’s 
extensive data are based on 7148 cases of lung cancer 
and 14208 controls.
For non-smokers spending 50 hours annually in 
caves with radon levels of 7000 Bq/m3, the risk of 
lung cancer per 1000 speleologists visiting caves at 
that level of radon will be 0·28 cases per year, and for 
smokers 6·6 cases. 
The mean levels in caves according to Hyland and 
Gunn (1994) in Britain is between 2,300 Bq/m3 
and 3,300 Bq/m3. The “average” risk to cavers in 
Britain, using Darby’s data should then, for every 
1000 cavers spending 50 hours per year in caves, be 
2200/7000 or 3300/7000, i.e. 0·088 cases per year 
to 0·13 cases per year for non-smokers, and 2·07 
cases and 3·11 cases per 1000 speleologists who 
are also smokers, respectively per year, based on 
averaged concentrations. Concentrations may vary a 
hundredfold, however.   
 DISCUSSION
Risk estimates from data are represented in this 
paper, from a 1/12500 (0·00008) lifetime risk of 
premature death from lung cancer risk for casual 
cavers spending 50 hours per week in caves with an 
average concentration of 7000 Bq/m3, to a lifetime risk 
to die of excess cancer of 1 in 1000 for professional 
cavers spending 600 hours per year (50 hours per 
month) in caves. (http://www.cavingireland.org/
safety/radon.htm).
We calculated risk for cavers spending 50 hours 
a year in caves based on the data from Darby et al. 
(2005). These risk estimates distinguish between 
smokers and non-smokers. These calculations give 
risk estimates of 0·00028 per cent, or 0·0000028 per 
individual for non-smokers, and a risk for smokers 
spending 50 hours per year in caves as 0·0066% for 
smokers or 0·000066 lifetime risk per individual.
With radon being such a strong carcinogen in the 
laboratory, and classed as a “class 1 carcinogen” why 
do we not see more cases lung cancer than we do?
We have a hypothesis that evolutionary forces help 
to protect the healthy respiratory system as natural 
selection would have tended to favour epithelia that 
would engender a survival advantage to members of a 
species with better developed epithelia, less vulnerable 
to radiation damage, in the airways. Ideally such an 
epithelium would have radio-resistant cells, or cells 
out of range of alpha particles, or cells readily affected 
by programmed cell death (apoptosis) if hit, or capable 
of activating tumour suppressor genes when genetic 
damage occurred.
Effective cilia that would remove offending particles 
rapidly would obviously constitute a beneﬁt not 
limited to obnoxious radioactive particles. Smoking is, 
relatively speaking, a very recent habit and exposure 
to such a concentrated cocktail of carcinogens would 
leave the resultant metaplastic epithelium largely 
defenceless - loss of cilia, metaplasia etc.
Mining is also a relatively recent activity in 
evolutionary terms, and the evidence mentioned 
above (Saccomanno et al., 1996) is that mining 
dust and smoking create the opportunity for the 
formation of larger particles that will tend to deposit 
centrally and cause inter alia, squamous metaplasia. 
Our hypothesis of evolutionary protection against 
radon therefore is based on, ﬁrstly, the thickness of 
the pseudo-stratiﬁed ciliated columnar epithelium. 
Simply stated, the path length of the alpha particles 
(about 45 microns) may not be long enough to reach 
the nuclear DNA of the target cells, or many if not 
most of them will be out of range.
The basal cells are likely to be present for the duration 
of the individual’s life, whereas the other cells (goblet 
cells and pseudo-stratiﬁed columnar epithelial cells 
etc.), may be replaced regularly and should be at a 
reduced risk for malignant transformation. 
As far as the “bystander effect” is concerned, it 
depends how far the oxygen radicals or hydroxyl 
radicals can reach. The range is only about 4 nano-
metres for the hydroxyl radicals, but cell to cell 
communication by chemical mediators may extend 
to nearby cells and explain part of the mutagenic 
potential of radon in vivo.
The possible effects of chronic bronchitis in non-
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smokers was not considered in the article by Darby et 
al. (2005). It is an aspect that may need research, as 
the basis of our hypothesis implies a normal, healthy 
epithelium of the respiratory tract. The attributable 
risk of radon in never-smokers without a history of 
asthma or chronic bronchitis may well prove to be 
lower still than the incidence in never-smokers.
It is of interest that Terzaghi-Howe (1994 & 1996; 
Terzaghi-Howe & Ford, 1994) studied the carcinogenic 
potential of alpha particles in the trachea of rats 
(intact trachea and cell cultures) whose respiratory 
epithelium closely resembles human respiratory 
epithelium, and whose habits may expose them 
naturally to larger doses of radon. She found that it 
is very difﬁcult to transform cells with alpha radiation 
alone, and suspects that it is necessary for malignant 
transformation to have the effects of other factors, such 
as the chemicals in tobacco smoke, also present.    
The United Nations Scientiﬁc Committee on the 
Effects of Atomic Radiation (2000) estimated that 
the mean radon concentrations in dwellings for 51 
countries with a population weighted concentration 
is 39 Bq/m3. If this is correct, then if the excess risk 
of lung cancer is about 16% per 100 Bq/m3 radon in 
homes should account for about 9% of the deaths due 
to lung cancer, and hence 2% of all cancer deaths 
in Europe. Clearly, the study by Darby et al. (2005) 
indicates that the risk level for never-smokers is very 
much lower than this ﬁgure, and that radon probably 
is not nearly as dangerous as is generally stated, 
provided that the respiratory epithelium is healthy 
and not compromised by disease or smoking. A certain 
percentage of the mining and general population may 
also have been cured of tuberculosis, which could also 
have damaged the larynx, trachea or bronchi. It may 
be a good study to compare carefully the epithelial 
thickness in healthy subjects (including the thickness 
of the mucous layer and cilia) to the range of alpha 
particles in this medium relative to the position of 
the nuclei of the cells most readily transformed. The 
effect of other respiratory diseases that can harm the 
bronchial epithelium should be taken into account in 
future epidemiological studies.
The failure of the authorities in Modum and 
Dobschau to report lung cancer in 1879 does not 
disprove our hypothesis. It must be remembered that 
at that time lung cancer had not been described in the 
medical literature. It is well known in medical circles 
that if we do not think of a certain diagnosis, we do 
not make that diagnosis. The doctors in those towns 
had probably never previously heard of lung cancer, 
and would not have considered it in the differential 
diagnosis of their miner patients with chronic lung 
disease.
There is a huge world literature on the subject 
of radon, smoking and lung cancer written by 
epidemiologists, environmentalists, radiation 
physicists, pathologists, clinicians and public health 
ofﬁcers. Some of it is controversial (e.g. Cohen, 2004), 
and may reﬂect the training, interests, remit and 
subconscious bias of the authors. Good examples of 
the tunnel vision of authors are two reports of the 
International Commission on Radiation Protection 
(ICRP) (Anon., 1987; Jacobi, 1993). They concentrated 
on ionizing radiation, and failed to assess adequately 
the contribution of tobacco smoke. A subsequent 
report of the ICRP cautioned that the effect of smoking 
on radon exposed miners is debatable. There may be 
other, unknown, carcinogens in the mines; and the 
smoking habits of the non-miner controls may differ 
from those of the miners (Masse & Cross, 1994). Care 
must be taken when extrapolating the results of in 
vivo and in vitro experiments, and epidemiological 
work done on miners, to cave visitors and employees.
This short paper does not attempt to summarise the 
literature. It serves to expand Cigna’s (2005) paper 
from the point of view of clinicians. We have the 
above good reasons to believe that radon per se, in 
the low concentrations found in caves (Ford, 1991), 
does not pose a high risk for non-smokers. Cigna 
(1987) himself has come to the same conclusion using 
different arguments. The International Commission on 
Radiological Protection (Anon., 1987) has considered 
the radon problem in mines and homes. It initially 
confused the cause and effect relationship, and referred 
to the, “possible synergistic inﬂuence of cigarette 
smoking”. It later again gave insufﬁcient attention to 
the probable confounding effect on tobacco smoke, and 
dismissed this important matter in the penultimate 
paragraph. Nevertheless it later concluded that in 
workplaces where public occupancy is low, such as 
libraries, ofﬁces and theatres, no special regulation 
and treatment is necessary (Jacobi, 1993). Caves can 
be considered to fall into this category.
We further believe that it is the co-carcinogenic 
effect of radon on tobacco smoke (not the other way 
round) which is the risk factor for miners’ lung cancer. 
We conﬁrm Cigna’s (2005) opinion that cave tourists 
and cave explorers spend insufﬁcient time in caves 
for them to be at signiﬁcant extra risk. However, show 
cave guides spend much of their working day in caves. 
It would therefore be prudent for tobacco smokers 
not to be employed as cave guides and in cave mouth 
buildings (Craven, 1997).
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APPENDIX 
A note about units.
Activity is expressed in Bequerels (Bq).
A Bequerel is deﬁned as one disintegration per second.
A Curie (Ci, an older unit) is equal to 3·7 x 1010 Bq.
A Working Level (WL) = 200 pCi per litre (7400 Bq/m3) at 
50% equilibrium of radon with its daughters.
One Working Level Month (WLM) = 170 hours of exposure 
in a workplace with one WL (or 170 hours of exposure to 
7400 Bq/m3.
One WLM = (occupational) exposure for 12 months (8 h/d, 5 
d/week) = 12 WLM/year, but at home with higher than 8 
hours occupation (12 h/d, 7 d/w) therefore 1 WL (home)= 
25·8 WLM/year.  
One WLM/year = 74 Bq/m3 (for 222Rn series).
At complete equilibrium, one pCi/litre results in an exposure 
equal to 0·01 working levels, but it is assumed that inside 
buildings the radon decay product/radon equilibrium 
is only 50%. Thus inside buildings, one pCi/l = 0·005 
working levels, or 1 WL = 200 pCi/l, and where 1 pCi/l = 
37 Bq/m3.
One WL is therefore equivalent to 7400 Bq/m3, one WLM 
= 1,258,000 or 1·258 megabequerel/l, and 1 WLY = 15·1 
MBq/l.
A count of 155,000 Bq/m3 = 0·155 Mbq or about 0·12 WLM.
 
Background radiation
 The total background radiation due to cosmic rays, radon, 
medical exposure etc. is given as an Effective Dose (ED) of 
360 millirem per year. Of this, radon is said to contribute 
200 millirem, as against 63 millirem total for artiﬁcial 
sources.
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